《中国糖尿病杂志》官方网站

20

您的位置:首页 > 中国糖尿病杂志 > 2012年 > 1期

尿C肽肌酐比值是门诊鉴别HNF1α/HNF4αMODY与长病程1型糖尿病的实用诊断工具

来自:中国糖尿病资讯网  编辑:editor|点击数:|2012-01-18

  ·国际研究动态·

  洪珊珊 摘译 钱荣立 审校

  译者单位:100034北京,本刊编辑部

  【提要】Besser REJ, Knight BA, Shepherd MH等的"Urinary C-peptide creatinine ratio (UCPCR) is a practical outpatient tool for identifying HNF1A/HNF4A MODY from long duration type 1 diabetes"(Diabetes Care,2011,34:286-291 )一文比较了成人中HNF1A/4A MODY、T1DM、T2DM中的UCPCR水平,证实了UCPCR是可用于鉴别HNF1α/HNF4α MODY与长期T1DM的非侵入性门诊诊断工具。并指出对于从病程>5年的T1DM和MODY的鉴别,UCPCR可用于确定是否需要基因检测。

  【关键词】糖尿病,1型;HNF1A/HNF4A MODY;尿C肽肌酐比值

  Urinary C-peptide creatinine ratio (UCPCR) is a practical outpatient tool for identifying HNF1A/HNF4A MODY from long duration type 1 diabetesHONG Shan-shan, QIAN Rong-li. Editorial Department of Chinese Journal of Diabetes, Beijing 100034, China

  【Summary】 Besser REJ, Knight BA, Shepherd MH, et al compared stimulated UCPCR in adults with HNF1A/4A MODY, type 1 diabetes, and type 2 diabetes in "Urinary C-peptide creatinine ratio (UCPCR) is a practical outpatient tool for identifying HNF1A/HNF4A MODY from long duration type 1 diabetes"(Diabetes Care,2011,34:286-291 ),and concluded UCPCR was a noninvasive outpatient tool that can be used to discriminate HNF1A and HNF4A MODY from long-duration type 1 diabetes. To differentiate MODY from type 1 diabetes of >5 years’ duration, UCPCR could be used to determine whether genetic testing is indicated.The essential parts were tanslated in the following article.

  【Key words】Diabetes Mellitus, type 1; HNF1A/HNF4A MODY; Urinary C-peptide creatinine ratio (UCPCR)

上一篇:代谢正常肥胖的研究进展 下一篇:大力开展转化医学研究,促进糖尿病防治指南的落实,努力实现国际糖尿病联盟全球糖尿病防治10年规划